Sughrue Mion, PLLC
Stabilized external preparation comprising thymosin beta 4 as an active ingredient
The present invention relates to a stabilized external preparation comprising thymosin beta 4 (Tβ4) as an active ingredient. More specifically, the present invention relates to a therapeutically effective external preparation with improved stability and biological activity of Tβ4. The preparation according to the present invention provides Tβ4 in a stable state by maintaining the biological activity of Tβ4 and minimizing the generation of Tβ4 sulfoxide through oxidization reactions and multimers through aggregation.
G-TREEBNT CO., LTD.
A A A A A A A A A
A61K A61K A61K A61K A61K A61K A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jun Won Tae Heum Kyoungsun Si Young
Choi Um Kim Lee